Rigel Pharmaceuticals Inc financial data

Symbol
RIGL on Nasdaq
Industry
Pharmaceutical Preparations
Location
611 Gateway Boulevard, Suite 900, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 164 % -20.4%
Quick Ratio 10.4 % -43%
Debt-to-equity -588 % +2.23%
Return On Equity -14.8 % -115%
Return On Assets 3.03 %
Operating Margin 6.03 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.6M shares -89.9%
Common Stock, Shares, Outstanding 175M shares +0.82%
Entity Public Float 223M USD +15%
Common Stock, Value, Issued 17K USD -90.3%
Weighted Average Number of Shares Outstanding, Basic 17.6M shares +0.94%
Weighted Average Number of Shares Outstanding, Diluted 17.6M shares +1.22%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 157M USD +19%
Costs and Expenses 148M USD -3.13%
Operating Income (Loss) 9.5M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -58.6M USD -238%
Income Tax Expense (Benefit) -60K USD
Net Income (Loss) Attributable to Parent 3.88M USD
Earnings Per Share, Basic 1.25 USD/shares
Earnings Per Share, Diluted 1.24 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 51.7M USD +13.8%
Cash, Cash Equivalents, and Short-term Investments 61.1M USD -1.98%
Accounts Receivable, after Allowance for Credit Loss, Current 30.6M USD +29.9%
Inventory, Net 4.78M USD -21.7%
Assets, Current 106M USD +12%
Property, Plant and Equipment, Net 99K USD -47.9%
Operating Lease, Right-of-Use Asset 405K USD -59.8%
Other Assets, Noncurrent 4.76M USD -3.94%
Assets 139M USD +20.9%
Accounts Payable, Current 3.82M USD -52.3%
Employee-related Liabilities, Current 7.92M USD -2.09%
Contract with Customer, Liability, Current 1.36M USD 0%
Liabilities, Current 54.3M USD +12.5%
Operating Lease, Liability, Noncurrent 100K USD -87.5%
Other Liabilities, Noncurrent 40M USD +3.15%
Liabilities 154M USD +4.69%
Accumulated Other Comprehensive Income (Loss), Net of Tax 11K USD
Retained Earnings (Accumulated Deficit) -1.4B USD +0.28%
Stockholders' Equity Attributable to Parent -14.6M USD +54%
Liabilities and Equity 139M USD +20.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.01M USD -23%
Net Cash Provided by (Used in) Financing Activities -2.51M USD -113%
Net Cash Provided by (Used in) Investing Activities 313K USD -59.7%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 175M shares +0.82%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 51.7M USD +13.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.68M USD +66.6%
Deferred Tax Assets, Valuation Allowance 339M USD +0.29%
Deferred Tax Assets, Gross 339M USD +0.29%
Operating Lease, Liability 8.3M USD -51.7%
Payments to Acquire Property, Plant, and Equipment 224K USD +215%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3.91M USD
Lessee, Operating Lease, Liability, to be Paid 488K USD -60.1%
Property, Plant and Equipment, Gross 1.87M USD -84%
Operating Lease, Liability, Current 466K USD -30.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 301K USD -59.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 301K USD -59.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 301K USD
Deferred Tax Assets, Operating Loss Carryforwards 230M USD -0.18%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 8.67M USD -8%
Operating Lease, Payments 734K USD -81.6%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.8M USD +100%
Depreciation, Depletion and Amortization 400K USD +12%
Share-based Payment Arrangement, Expense 12.2M USD +11.7%
Interest Expense 7.87M USD +29.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%